CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: trabectedin
Accession: CHEBI:84050
browse the term
Definition: A tetrahydroisoquinoline alkaloid obtained from a Caribbean tunicate Ecteinascidia turbinata. Used for the treatment of soft tissue sarcoma and relapsed ovarian cancer.
Synonyms: exact_synonym: (6R,6aR,7R,13S,14S,16R,20R)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-19-oxo-3',4',6,7,12,13,14,16-octahydro-2'H,6aH-spiro[7,13-epimino-6,16-(epithiopropanooxymethano)[1,3]dioxolo[7,8]isoquinolino[3,2-b][3]benzazocine-20,1'-isoquinolin]-5-yl acetate
related_synonym: ET-743; ET743; Ect 743; Ecteinascidin; Ecteinascidin 743; Formula=C39H43N3O11S; InChI=1S/C39H43N3O11S/c1-16-9-20-10-22-37(46)42-23-13-50-38(47)39(21-12-25(48-5)24(44)11-19(21)7-8-40-39)14-54-36(30(42)29(41(22)4)26(20)31(45)32(16)49-6)28-27(23)35-34(51-15-52-35)17(2)33(28)53-18(3)43/h9,11-12,22-23,29-30,36-37,40,44-46H,7-8,10,13-15H2,1-6H3/t22-,23-,29+,30+,36+,37-,39+/m0/s1; InChIKey=PKVRCIRHQMSYJX-AIFWHQITSA-N; SMILES=COc1cc2c(CCN[C@]22CS[C@H]3[C@H]4[C@@H]5N(C)[C@@H](Cc6cc(C)c(OC)c(O)c56)[C@H](O)N4[C@@H](COC2=O)c2c4OCOc4c(C)c(OC(C)=O)c32)cc1O; Yondelis
xref: CAS:114899-77-3; DrugBank:DB05109; Drug_Central:4633; HMDB:HMDB0015609; KEGG:C16875; KEGG:D06199
xref_mesh: MESH:C099150
xref: PMID:18728699; PMID:21403840; PMID:21499557; PMID:23149213; PMID:24001124; PMID:24277455; PMID:24662672; PMID:24692579; PMID:24696229; PMID:24707261; PMID:24755886; PMID:24756367; PMID:24803896; PMID:24844217; PMID:24917554; PMID:24941346; PMID:24982387; PMID:25048043; PMID:25048044; PMID:25050069; PMID:25076252; PMID:25100135; PMID:25209722; PMID:25263179; PMID:25273374; PMID:25479910; Reaxys:7617615; Wikipedia:Trabectedin
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions increases expression
ISO EXP
[ABCB1A protein mutant form co-treated with ABCB1B protein mutant form] results in increased susceptibility to trabectedin trabectedin results in increased expression of ABCB1A mRNA
CTD
PMID:12154027 PMID:19238326
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
multiple interactions increases expression
ISO EXP
[ABCB1A protein mutant form co-treated with ABCB1B protein mutant form] results in increased susceptibility to trabectedin trabectedin results in increased expression of ABCB1B mRNA
CTD
PMID:12154027 PMID:19238326
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Aco1
aconitase 1
increases expression
ISO
Trabectedin results in increased expression of ACO1 mRNA; Trabectedin results in increased expression of ACO1 protein
CTD
PMID:36396105
NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:55,259,827...55,316,391
G
Car3
carbonic anhydrase 3
decreases expression
EXP
trabectedin results in decreased expression of CAR3 mRNA
CTD
PMID:12154027
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
G
Ccna2
cyclin A2
decreases expression
ISO
trabectedin results in decreased expression of CCNA2 mRNA
CTD
PMID:15961672
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
decreases expression
ISO
trabectedin results in decreased expression of CCNB1 mRNA
CTD
PMID:15961672
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
G
Ccnb2
cyclin B2
decreases expression
ISO
trabectedin results in decreased expression of CCNB2 mRNA
CTD
PMID:15961672
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccnd1
cyclin D1
increases expression
EXP
trabectedin results in increased expression of CCND1 mRNA
CTD
PMID:12154027
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccne1
cyclin E1
increases expression
ISO
trabectedin results in increased expression of CCNE1 mRNA
CTD
PMID:15961672
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Cdk1
cyclin-dependent kinase 1
increases expression
EXP
trabectedin results in increased expression of CDK1 mRNA
CTD
PMID:12154027
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases expression
EXP
trabectedin results in decreased expression of CYP1A2 mRNA
CTD
PMID:12154027
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity
EXP
trabectedin results in decreased activity of CYP2E1 protein
CTD
PMID:12154027
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases activity decreases expression
EXP
trabectedin results in decreased activity of CYP3A2 protein Trabectedin results in decreased expression of CYP3A11 mRNA
CTD
PMID:12154027
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
multiple interactions
EXP
Trabectedin inhibits the reaction [2-Acetylaminofluorene results in increased expression of CYP3A23-3A1 mRNA]
CTD
PMID:12504080
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
decreases expression
EXP
trabectedin results in decreased expression of CYP3A13 mRNA
CTD
PMID:12154027
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Dhfr
dihydrofolate reductase
decreases expression
ISO
trabectedin results in decreased expression of DHFR mRNA
CTD
PMID:15961672
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
E2f1
E2F transcription factor 1
increases expression
ISO
trabectedin results in increased expression of E2F1 mRNA
CTD
PMID:15961672
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
Gpx4
glutathione peroxidase 4
decreases expression
ISO
Trabectedin results in decreased expression of GPX4 mRNA; Trabectedin results in decreased expression of GPX4 protein
CTD
PMID:36396105
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Hif1a
hypoxia inducible factor 1 subunit alpha
increases expression
ISO
Trabectedin results in increased expression of HIF1A mRNA; Trabectedin results in increased expression of HIF1A protein
CTD
PMID:36396105
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Keap1
Kelch-like ECH-associated protein 1
increases expression
ISO
Trabectedin results in increased expression of KEAP1 protein
CTD
PMID:36396105
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Mki67
marker of proliferation Ki-67
increases expression
EXP
trabectedin results in increased expression of MKI67 protein
CTD
PMID:12154027
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions decreases response to substance
ISO
everolimus inhibits the reaction [MTOR results in decreased susceptibility to trabectedin]
CTD
PMID:21622721
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases expression
ISO
Trabectedin results in decreased expression of NFE2L2 protein
CTD
PMID:36396105
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfya
nuclear transcription factor Y subunit alpha
multiple interactions
ISO
trabectedin affects the activity of [NFYA protein binds to NFYB protein binds to NFYC protein]
CTD
PMID:15961672
NCBI chr 9:12,587,437...12,613,911
Ensembl chr 9:12,586,259...12,613,898
G
Nfyb
nuclear transcription factor Y subunit beta
multiple interactions
ISO
trabectedin affects the activity of [NFYA protein binds to NFYB protein binds to NFYC protein]
CTD
PMID:15961672
NCBI chr 7:20,964,988...20,980,569
Ensembl chr 7:20,964,993...20,980,565
G
Nfyc
nuclear transcription factor Y subunit gamma
multiple interactions
ISO
trabectedin affects the activity of [NFYA protein binds to NFYB protein binds to NFYC protein]
CTD
PMID:15961672
NCBI chr 5:134,336,802...134,405,372
Ensembl chr 5:134,336,808...134,405,377
G
Tfrc
transferrin receptor
increases expression
ISO
Trabectedin results in increased expression of TFRC mRNA; Trabectedin results in increased expression of TFRC protein
CTD
PMID:36396105
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tk1
thymidine kinase 1
decreases expression
ISO
trabectedin results in decreased expression of TK1 mRNA
CTD
PMID:15961672
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all